STOCK TITAN

[Form 4] Nutanix, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Nutanix, Inc. (NTNX) Form 4: Chief Legal Officer Brian Martin reported sales and remaining holdings on 09/30/2025. He sold 10,241 shares of Class A common stock in multiple transactions at a weighted average price of $76.5288 per share under a Rule 10b5-1 trading plan adopted July 1, 2025. Following the reported sale, the filing shows 5,166 shares beneficially owned. The report also notes acquisition of 229 shares under the company Employee Stock Purchase Plan on 09/22/2025. The Form 4 was signed by an attorney-in-fact, Raymond Hum.

Nutanix, Inc. (NTNX) Modulo 4: Il Direttore Legale Capo, Brian Martin, ha riportato vendite e azioni rimanenti al 30/09/2025. Ha venduto 10.241 azioni di Classe A in diverse operazioni, a un prezzo medio ponderato di 76,5288 USD per azione, secondo un piano di negoziazione Rule 10b5-1 adottato il 1° luglio 2025. Dopo la vendita riportata, la dichiarazione indica una detenzione beneficiaria di 5.166 azioni. Il rapporto segnala anche l’acquisizione di 229 azioni nell’ambito del Piano di Acquisto Azioni per Dipendenti (ESPP) della società il 22/09/2025. Il Form 4 è stato firmato da un procuratore, Raymond Hum.
Nutanix, Inc. (NTNX) Formulario 4: El Director Jurídico General, Brian Martin, informó sobre ventas y participaciones restantes al 30/09/2025. Vendió 10.241 acciones comunes de Clase A en varias operaciones a un precio medio ponderado de 76,5288 USD por acción, bajo un plan de negociación Rule 10b5-1 aprobado el 1 de julio de 2025. Tras la venta reportada, el archivo muestra 5.166 acciones poseídas de forma beneficiosa. El informe también señala la adquisición de 229 acciones bajo el Plan de Compra de Acciones para Empleados (ESPP) de la empresa el 22/09/2025. El Formulario 4 fue firmado por un agente, Raymond Hum.
Nutanix, Inc. (NTNX) Form 4: 최고 법무책임자 브라이언 마틴은 2025년 9월 30일 기준의 매도 및 남은 보유 주식을 보고했습니다. 그는 2025년 7월 1일에 채택된 Rule 10b5-1 매매 계획에 따라 가중 평균가 76.5288 USD로 A클래스 일반주 10,241주를 여러 차례 매도했습니다. 보고된 매도 후 파일은 5,166주를 유익하게 보유하고 있음을 나타냅니다. 또한 2025년 9월 22일에 회사의 직원 주식매수 계획(ESPP) 하에 229주를 취득한 것으로 기록되어 있습니다. 이 Form 4는 변호사 대리인 Raymond Hum이 서명했습니다.
Nutanix, Inc. (NTNX) Formulaire 4 : Le directeur juridique en chef, Brian Martin, a rendu compte des ventes et des actions restant au 30/09/2025. Il a vendu 10 241 actions ordinaires de classe A lors de plusieurs transactions, à un prix moyen pondéré de 76,5288 USD par action, dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 1er juillet 2025. Après la vente déclarée, le dossier indique 5 166 actions détenues qui bénéficient d’un droit. Le rapport indique également l’acquisition de 229 actions dans le cadre du plan d’achat d’actions des employés (ESPP) de l’entreprise le 22/09/2025. Le Formulaire 4 a été signé par un mandataire, Raymond Hum.
Nutanix, Inc. (NTNX) Formular 4: Der Chief Legal Officer Brian Martin hat Verkäufe und verbleibende Bestände zum 30.09.2025 gemeldet. Er verkaufte 10.241 Class-A-Namenaktien in mehreren Transaktionen zu einem gewichteten Durchschnittspreis von 76,5288 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans, der am 01.07.2025 angenommen wurde. Nach dem gemeldeten Verkauf zeigt die Einreichung 5.166 Aktien, die begünstigt gehalten werden. Der Bericht vermerkt außerdem den Erwerb von 229 Aktien im Rahmen des Employee Stock Purchase Plan (ESPP) des Unternehmens am 22.09.2025. Das Form 4 wurde von einem Bevollmächtigten, Raymond Hum, unterschrieben.
نوتانيكس، إنك. (NTNX) النموذج 4: أبلغ كبير مسؤولي الشؤون القانونية بريان مارتن عن المبيعات والملكيات المتبقية حتى تاريخ 30/09/2025. باع 10,241 سهمًا من فئة أ من الأسهم العادية في عدة معاملات بسعر تقريبي وزني قدره 76.5288 دولارًا للسهم، وفقًا لخطة تداول Rule 10b5-1 المعتمدة في 01/07/2025. بعد البيع المبلغ عنه، يظهر الملف أن لديه 5,166 سهمًا مملوكًا لصالحه. كما يشير التقرير إلى اكتساب 229 سهمًا بموجب خطة شراء أسهم الموظفين (ESPP) للشركة في 22/09/2025. تم توقيع النموذج 4 من قِبل وكيل، رايموند هوم.
Nutanix, Inc.(NTNX) Form 4:首席法务官 Brian Martin 于 2025-09-30 报告了销售及剩余持股情况。他在截至 2025-07-01 通过一种 Rule 10b5-1 交易计划进行多笔交易,拟合加权平均价为每股 76.5288 美元,出售了 10,241 股 A 类普通股。报告的出售后,文件显示其受益持有为 5,166 股。报告还记载于 2025-09-22 通过公司员工股票购买计划(ESPP)购买了 229 股。该 Form 4 由代理律师 Raymond Hum 签署。
Positive
  • Sale executed under a Rule 10b5-1 plan, indicating pre-established trading and compliance with insider-trading procedures
  • Disclosure includes ESPP purchase of 229 shares on 09/22/2025, showing continued participation in employee equity programs
  • Form 4 filed and signed by attorney-in-fact, demonstrating procedural compliance with SEC reporting requirements
Negative
  • Insider sold 10,241 shares, reducing beneficial ownership to 5,166 shares
  • Sale at market prices between $76.24 and $76.88 may be viewed by some investors as insider liquidity rather than conviction

Insights

TL;DR: Routine insider sale under a pre-established plan; transaction provides liquidity but does not necessarily signal change in company outlook.

The sale of 10,241 shares at a weighted average of $76.5288 was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled rather than opportunistic. The remaining beneficial ownership reported is 5,166 shares, and a small ESPP purchase of 229 shares was recorded on 09/22/2025. For investors, this filing documents insider activity and compliance procedures but contains no operational or financial performance data.

TL;DR: Governance-wise the filing shows adherence to trading-plan procedures and proper disclosure by an officer via power of attorney.

The disclosure identifies the reporting person as an officer (Chief Legal Officer) and cites a Rule 10b5-1 trading plan adopted July 1, 2025, which supports compliance with insider-trading rules. The Form 4 is signed by an attorney-in-fact, consistent with authorized filing practices. The filing contains no indications of unusual timing or related-party transactions.

Nutanix, Inc. (NTNX) Modulo 4: Il Direttore Legale Capo, Brian Martin, ha riportato vendite e azioni rimanenti al 30/09/2025. Ha venduto 10.241 azioni di Classe A in diverse operazioni, a un prezzo medio ponderato di 76,5288 USD per azione, secondo un piano di negoziazione Rule 10b5-1 adottato il 1° luglio 2025. Dopo la vendita riportata, la dichiarazione indica una detenzione beneficiaria di 5.166 azioni. Il rapporto segnala anche l’acquisizione di 229 azioni nell’ambito del Piano di Acquisto Azioni per Dipendenti (ESPP) della società il 22/09/2025. Il Form 4 è stato firmato da un procuratore, Raymond Hum.
Nutanix, Inc. (NTNX) Formulario 4: El Director Jurídico General, Brian Martin, informó sobre ventas y participaciones restantes al 30/09/2025. Vendió 10.241 acciones comunes de Clase A en varias operaciones a un precio medio ponderado de 76,5288 USD por acción, bajo un plan de negociación Rule 10b5-1 aprobado el 1 de julio de 2025. Tras la venta reportada, el archivo muestra 5.166 acciones poseídas de forma beneficiosa. El informe también señala la adquisición de 229 acciones bajo el Plan de Compra de Acciones para Empleados (ESPP) de la empresa el 22/09/2025. El Formulario 4 fue firmado por un agente, Raymond Hum.
Nutanix, Inc. (NTNX) Form 4: 최고 법무책임자 브라이언 마틴은 2025년 9월 30일 기준의 매도 및 남은 보유 주식을 보고했습니다. 그는 2025년 7월 1일에 채택된 Rule 10b5-1 매매 계획에 따라 가중 평균가 76.5288 USD로 A클래스 일반주 10,241주를 여러 차례 매도했습니다. 보고된 매도 후 파일은 5,166주를 유익하게 보유하고 있음을 나타냅니다. 또한 2025년 9월 22일에 회사의 직원 주식매수 계획(ESPP) 하에 229주를 취득한 것으로 기록되어 있습니다. 이 Form 4는 변호사 대리인 Raymond Hum이 서명했습니다.
Nutanix, Inc. (NTNX) Formulaire 4 : Le directeur juridique en chef, Brian Martin, a rendu compte des ventes et des actions restant au 30/09/2025. Il a vendu 10 241 actions ordinaires de classe A lors de plusieurs transactions, à un prix moyen pondéré de 76,5288 USD par action, dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 1er juillet 2025. Après la vente déclarée, le dossier indique 5 166 actions détenues qui bénéficient d’un droit. Le rapport indique également l’acquisition de 229 actions dans le cadre du plan d’achat d’actions des employés (ESPP) de l’entreprise le 22/09/2025. Le Formulaire 4 a été signé par un mandataire, Raymond Hum.
Nutanix, Inc. (NTNX) Formular 4: Der Chief Legal Officer Brian Martin hat Verkäufe und verbleibende Bestände zum 30.09.2025 gemeldet. Er verkaufte 10.241 Class-A-Namenaktien in mehreren Transaktionen zu einem gewichteten Durchschnittspreis von 76,5288 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans, der am 01.07.2025 angenommen wurde. Nach dem gemeldeten Verkauf zeigt die Einreichung 5.166 Aktien, die begünstigt gehalten werden. Der Bericht vermerkt außerdem den Erwerb von 229 Aktien im Rahmen des Employee Stock Purchase Plan (ESPP) des Unternehmens am 22.09.2025. Das Form 4 wurde von einem Bevollmächtigten, Raymond Hum, unterschrieben.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Martin Brian

(Last) (First) (Middle)
C/O NUTANIX, INC.
1740 TECHNOLOGY DR., SUITE 150

(Street)
SAN JOSE CA 95110

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nutanix, Inc. [ NTNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/30/2025 S 10,241(1) D $76.5288(2) 5,166(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 1, 2025.
2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $76.24 to $76.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Includes 229 shares of Class A Common Stock acquired under the Nutanix, Inc. Employee Stock Purchase Plan on September 22, 2025.
/s/ Raymond Hum, Attorney in Fact 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NTNX insider Brian Martin report on Form 4?

The Form 4 reports that Brian Martin sold 10,241 shares of Class A common stock on 09/30/2025 at a weighted average price of $76.5288 per share.

Was the NTNX sale part of a pre-arranged trading plan?

Yes. The filing states the transaction was effected automatically under a Rule 10b5-1 trading plan adopted on July 1, 2025.

How many NTNX shares does Brian Martin own after the reported transactions?

The Form 4 reports 5,166 shares beneficially owned following the reported sale.

Did the filing report any purchases of NTNX stock?

Yes. The filing includes acquisition of 229 shares under the Nutanix Employee Stock Purchase Plan on 09/22/2025.

Who signed the Form 4 for Brian Martin?

The Form 4 was signed by an attorney-in-fact, Raymond Hum, on 09/30/2025.
Nutanix Inc

NASDAQ:NTNX

NTNX Rankings

NTNX Latest News

NTNX Latest SEC Filings

NTNX Stock Data

20.68B
262.07M
0.59%
88.82%
2.89%
Software - Infrastructure
Services-prepackaged Software
Link
United States
SAN JOSE